Cryosite Limited Stock (CTE.AU) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

Cryosite Limited

CTE.AU

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Cryosite Limited Releases 2025 Corporate Governance Statement

Cryosite Limited has released its corporate governance statement for the financial year ending June 30, 2025, detailing adherence to ASX Corporate Governance Council’s recommendations. The statement outlines governance practices, including board responsibilities and director appointment processes, emphasizing transparency and accountability. This commitment to robust governance may enhance the company's reputation among stakeholders. The latest analyst rating for Cryosite Limited (AU:CTE) is a Buy with a price target of A$1.00.

Tip Ranks·08/21/2025 15:58

Cryosite Limited Reports Strong Half-Year FY25 Results and Facility Expansion

Cryosite Limited (AU:CTE) has reported strong financial results for the first half of FY25, with increased revenue and EBITDA due to high-margin services and cost control. The company has expanded its South Granville facility, doubling its capacity for freezers and liquid nitrogen tanks, enhancing its growth potential in the biological storage sector. Cryosite serves clients in clinical research, pharmaceuticals, and biotechnology. Current market cap is A$38.07M, with a year-to-date price performance of -8.24% and a consensus rating of Sell.

Tip Ranks·02/20/2025 14:18